ACTINIUM PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $18.0M | $20.5M |
| FY2017 | — | $13.7M | $17.4M |
| FY2018 | — | $8.8M | $13.7M |
| FY2019 | — | $5.6M | $9.3M |
| FY2020 | — | $61.3M | $63.6M |
| FY2021 | — | $73.5M | $77.8M |
| FY2022 | — | $66.5M | $108.9M |
| FY2023 | — | $36.4M | $76.7M |
| FY2024 | — | $32.8M | $72.9M |
| FY2025 | — | $7.8M | $48.0M |